Klin Farmakol Farm. 2015;29(2):73-76

Asthma treatment 2015

Václav Špičák
Alergologie a klinická imunologie, Immuno-flow, Praha

Asthma is one of the noncommunicable chronicrespitatory inflammatory diseases. Asthma represents important social and economic

burden. WHO initiated Global Initiative for Asthma (GINA). The first strategy of diagnostic, treatment and prevention of asthma was

published 1995. Czech Initiative for Athma was established 1996. The implementation of the new strategy was succesful. Mortality for

asthma significantly decreased, the hospitalityy for asthma is low and quality of life of asthmatics is better. The 2014 version of Global

Strategy on Asthma Management, Global Strategy of diagnostic, treatment and prevention of bronchial asthma represents the background

of our praxis. Our Society of allergologists and clinical immunologists and Society of pulmonology and ftiseology prepared

new Guidelines for dianostics and treatment of asthma.

Keywords: global initiative for asthma (GINA), Guidelines for asthma diagnosis and treatment, antiasthmatics, alergen immunotherapy

Published: July 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Špičák V. Asthma treatment 2015. Klin Farmakol Farm. 2015;29(2):73-76.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Global Strategy for Asthma Management, 2014, Global Initiative for Asthma, www.ginasthma.org.
    2. Teřl M, et al. Doporučený postup diagnostiky a léčby bronchiálního astmatu, GEUM 2015.
    3. Sedlák V, a spol. Doporučený postup diagnostiky a léčby obtížně léčitelného bronchiálního astmatu, Národní centrum pro těžké astma, s. 21, ČPFS.
    4. Kašák V. Asthma bronchiale,farmakoterapie u dospělých prizmatem doporučení GINA 2014. Acta Meducinae, 2014: 4.
    5. Kašák V. Cholinergní mechanismus u astmatu se vrací na scénu Alergie 2014; 16(Suppl.1): 31-36.
    6. Špičák V, Kašák V, Kašáková E. Jak udržet astma pod kontrolou? Jalna, ČIPA 2014: 48s.
    7. Špičák V. Století specifické alergenové imunoterapie, Alergie 2011; Suppl. 1: 4-24.
    8. Shankar T, Petrov AA. Omalizumab a hypersenzitivní reakce, Curr. Opin.Allergy Clin, Immunology/Cs, 2013; 10: 32-34.
    9. Bousquet J, et all. Integrated care pathways for airway diseases, Eur.Resp.J. 2014; 44: 304-323. Go to original source... Go to PubMed...
    10. Kašák V. Léčba astmatu-pohled do budoucnosti. Alergie 2011; Suppl. 2, 13, 19-28.

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.